Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
   
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  SWAN Knowledge Base
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Pathways
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Rotterdam Study Questions Links between Fat and Dementia Risk
24 December 2002. In conflict with a number of recent studies, six-year data from the Rotterdam study of aging failed to show a link between dietary fat and risk of dementia. The results are reported in today’s Neurology.

Drawing on disparate lines of evidence, some researchers have been building a case that dietary fat intake affects dementia risk (see related news item). For example, higher dietary cholesterol increased cerebral Aβ deposition in some animal experiments, and certain polyunsaturated fats may have antiinflammatory properties, which might counteract the alleged inflammatory contribution to dementia. Some, but not all, epidemiologic studies have linked higher serum levels of cholesterol (mostly during midlife) with higher dementia risk, and cholesterol-lowering drugs such as statins appear to reduce the risk of Alzheimer's dementia. Indeed, earlier results from the Rotterdam study have contributed to this theory (see Kalmijn et al., 1997), finding that high intake of total fat and low intake of fish (with its high levels of cis n-3 polyunsaturated fatty acids) were significantly associated with risk of dementia at the two-year follow-up in the Rotterdam study.

Now Monique Breteler and her colleagues in the Netherlands at the Erasmus Medical Center and at the University of Utrecht report the findings of six years of follow-up in the study of elderly residents (55 years or older at baseline) of a suburb of Rotterdam. Of the 5,395 subjects whose baseline and follow-up exams included complete dietary data, 197 (seven percent) had developed dementia (146 with AD; 29 with vascular dementia; and 22 with other dementias).

The researchers found no contribution to dementia risk from the intake of total fat, saturated fatty acids, or trans-unsaturated fatty acids, or from dietary cholesterol (adjusted for age, gender, total energy intake, and vitamin E intake). Conversely, dietary intake of the so-called "good" fatty acids, the cis mono- or polyunsaturated fatty acids, failed to reduce AD risk. These findings held true for all dementias, vascular dementia, and AD, and when additional lifestyle elements were factored in (e.g., smoking, alcohol, fruit and vegetables, dietary supplements, body mass index). Similarly, excluding patients using lipid-lowering drugs, or those with myocardial infarction or diabetes, did not change the results.

"Given the limited number of studies on fat intake and risk of dementia, we think it is premature to conclude from our observational study that cholesterol or cholesterol-affecting fats are not associated with risk of dementia or its subtypes. Larger, prospective studies with longer follow-up periods are needed to confirm our findings," the authors caution in their conclusion.Hakon Heimer.

References:
Englehart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JCM, Breteler MMB. Diet and risk of dementia: Does fat matter? Neurol. 2002;59:1915-21. Abstract

See ARF related live discussion.

 
Comments on News and Primary Papers
Comment by:  Benjamin Wolozin, ARF Advisor (Disclosure)
Submitted 24 December 2002 Posted 24 December 2002

See comment by Benjamin Wolozin
See reply by Monique Breteler

Comment by Benjamin Wolozin: Thinking about brain and serum cholesterol metabolism in Alzheimer’s disease.—Posted 24 December 2002.
The recent study by Engelhart and colleagues investigates the relationship of serum cholesterol and serum polyunsaturated fatty acids (PUFA) to the incidence of Alzheimer’s disease in the cohort of patients present in the Rotterdam study. Engelhart et al. do not observe any clear relationship between the intake of cholesterol, total PUFA, n-3 PUFA or n-6 PUFA and the incidence of Alzheimer’s disease.

The literature on the relationship between cholesterol and Alzheimer’s disease is quite confusing, and at times contradictory. Studies in cell culture, transgenic mice, and rabbits indicate that production of Aβ is sensitive to cellular cholesterol. Reducing cholesterol, by treating with β-methylcyclodextran, statins, or BM15.766 (a cholesterol-lowering drug that acts distal to HMG CoA...  Read more

View all comments by Benjamin Wolozin


Comment by:  Jose Luchsinger, Richard Mayeux, ARF Advisor
Submitted 24 December 2002 Posted 24 December 2002

This is a report of a large cohort study finding no association between dietary fat consumption and risk of dementia. The large size and long follow-up of the cohort, and the use of validated measures of dietary intake and diagnosis of dementia support the validity of the findings. There is one large omission in the study, however. The effect of the ApoE-ε4 allele on the association between dietary fats and incident dementia is not considered. Previous studies have found an association between high intake of fats and incident Alzheimer's disease in individuals with the ApoE-ε4 allele (Neurobiol Aging. 2000;21 (suppl):S246. Abstract 1124.; Arch Neurol. 2002 Aug;59(8):1258-63), and the ApoE gene has been reported to modulate the effects of dietary exposures (Am J Clin Nutr. 2001;73:669-70). Judgment on the findings of this study by Engelhart et al. should be withheld until analyses stratified by the presence of the ApoE-ε4 allele are reported.

View all comments by Jose Luchsinger
View all comments by Richard Mayeux

Comment by:  Alexei R. Koudinov
Submitted 4 January 2003 Posted 4 January 2003

This report is one of nearly 40 others on Alzheimer's disease by the same research group using the Rotterdam study data. The article sets out to test the hypothesis that "cholesterol increases and n-3 PUFA reduce dementia risk." The results do not prove the hypothesis, and the article describes the study limitations and makes readers aware that "larger, prospective studies with longer follow-up periods are needed to confirm our findings." I see additional flaws in this study. First, it excludes data and discussion of ApoE allele variants despite their obvious importance in lipid metabolism. The same investigators reported on this significance earlier this year in another report on diet and AD on the same study population (see Engelhart, 2002). Second, I remain unconvinced by the authors' discussion of the discrepancy between the results of their previous article (Kalmijn, 1997) on the identical subject and this current article. In spite of this,...  Read more

View all comments by Alexei R. Koudinov

Comment by:  Monique MB Breteler
Submitted 17 January 2003 Posted 17 January 2003

We appreciate the comment by Jose Luchsinger and Richard Mayeux. We did not include the results of our analyses stratified according to apoE genotype but we agree that this is relevant additional information. We found no relation between the various measures of dietary fat intake and risk of dementia and subtypes of dementia, and this was similar across strata of ApoE genotype.

Benjamin Wolozin lists several factors that are related to cholesterol and possibly to risk of Alzheimer’s disease (statin use, serum cholesterol levels, dietary fat intake, brain cholesterol metabolism). Obviously, this does not imply that if they are indeed related to risk of Alzheimer's disease this is all through the same mechanism, nor that this is always through a direct effect of cholesterol.

The studies that did observe a relation between plasma cholesterol levels and risk of AD evaluated mid-life cholesterol levels in relation to late-life dementia risk (Kivipelto et al., 2002; Kivipelto et al., 2001; Notkola et al., 1998). It is well conceivable that this relation is mediated by a...  Read more

View all comments by Monique MB Breteler

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2010 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad